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Background
Central Nervous System (CNS) disorders often accom-
pany the acquired immunodeficiency syndrome (AIDS)
and are typified by neuropsychiatric symptoms, such as
cognitive and motor impairments, sometimes paralleled
by neuropathological hallmarks. Collectively, these events
are referred to as HIV-1 associated dementia (HAD).
Before the advent of the Highly Active Antiretroviral
Therapy (HAART), about 20% of adult patients, but as
many as 40% of children/adolescent infected subjects
developed HAD. Nowadays, in the era of HAART, the
prevalence of HAD has decreased, but a more subtle
form of disorder, referred to as Minor Cognitive Motor
Disorder (MCMD), has emerged in about 20% of sympto-
matic HIV-1 seropositive patients, including those receiv-
ing HAART. This work was aimed at investigating the
impact of the HIV-1 viral protein Tat on central neuro-
transmission since this protein has been proposed as one
of the viral component involved in the onset of central
neuropsychiatric symptoms.
Methods
The approach used was the up-down superfusion of
purified synaptosomes isolated from human neocortical
specimens removed during neurosurgery from consent-
ing patients suffering of brain tumours. Experiments
were also carried out by using mouse purified synapto-
somes or slices in an attempt to propose an animal
model suitable to investigate Tat-induced modification
to central nervous system. Functional studies were
paralleled by biochemical investigation on the existence
of receptor protein potential involved in the effects
observed and changes to second messenger production.
Results
Human immunodeficiency virus-1 (HIV-1)-encoded trans-
activator of transcription (Tat) potentiated the depolariza-
tion-evoked exocytosis of [3H]D-aspartate ([3H]D-ASP)
from human neocortical terminals. The metabotropic glu-
tamate (mGlu) 1 receptor antagonist CPCCOEt prevented
this effect, whereas the mGlu5 receptor antagonist MPEP
was ineffective. Western blot analysis showed that human
neocortex synaptosomes possess mGlu1 and mGlu5
receptors. Tat potentiated the K+-evoked release of [3H]
D-ASP or of endogenous glutamate from mouse neocorti-
cal synaptosomes in a CPCCOEt-sensitive, MPEP-insensi-
tive manner. Deletion of mGlu1 receptors (crv4/crv4
mice) or mGlu5 receptors (mGlu5-/-mouse) silenced Tat
effects, suggesting that mGlu1 and mGlu5 receptors are
co-express on glutamatergic terminals. Tat enhanced ino-
sitol 1,4,5-trisphosphate production in human and mouse
neocortical synaptosomes, consistent with the involvement
of group I mGlu receptors. Tat inhibited the K+-evoked
release of [3H]GABA from human synaptosomes and that
of endogenous GABA or [3H]GABA from mouse nerve
terminals; the inhibition was insensitive to CPCCOEt or
MPEP. In mouse neocortical slices, Tat facilitated the K+-
and the veratridine-induced release of [3H]D-ASP in a
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These observations are relevant to the comprehension of
the pathophysiological effects of Tat in central nervous
system and may suggest new potential therapeutic
approaches to the cure of HIV-1 associated dementia.
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